Please assess the completion status of the following clinical trial:

Trial Title: Fecal Microbiota Transplantation for Ulcerative Colitis

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Mild to moderate UC.~Exclusion Criteria:~* Antibiotic exposure in the last 3 months.~* Biologic or immunomodulatory therapy within the last 3 months.~* Corticosteroid therapy or probiotics within the last 2 weeks.~* Severely active disease (defined as Mayo scores of 10 or greater, or patients with endoscopic disease activity scores of 3 or greater).

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fecal Microbiota Transplantation (Type: EXPERIMENTAL): Fecal Microbiota Transplantation by colonoscopic delivery of stool to the right colon.

Based on this trial design, predict the completion outcome and termination type (if applicable).